Annette Baumhauer

4.1k total citations
9 papers, 351 citations indexed

About

Annette Baumhauer is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Annette Baumhauer has authored 9 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Hepatology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Annette Baumhauer's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Treatment and Pharmacology (4 papers). Annette Baumhauer is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cancer Treatment and Pharmacology (4 papers). Annette Baumhauer collaborates with scholars based in Spain, Germany and United States. Annette Baumhauer's co-authors include Yi‐Hsiang Huang, Jordi Bruix, Philippe Merle, Olivier Rosmorduc, Osamu Yokosuka, G. Bodoky, René Gerolami, Alessandro Granito, Gerold Meinhardt and Weijing Sun and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Hepatology.

In The Last Decade

Annette Baumhauer

9 papers receiving 347 citations

Peers

Annette Baumhauer
Maria Lamar United States
Liangliang Qiao China
Yu-Jie Xu China
Ruocai Xu China
Fei Cao China
Songqiang Zhou China
Guohong Han China
Xuqi Sun China
J. Zou United States
Maria Lamar United States
Annette Baumhauer
Citations per year, relative to Annette Baumhauer Annette Baumhauer (= 1×) peers Maria Lamar

Countries citing papers authored by Annette Baumhauer

Since Specialization
Citations

This map shows the geographic impact of Annette Baumhauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annette Baumhauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annette Baumhauer more than expected).

Fields of papers citing papers by Annette Baumhauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annette Baumhauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annette Baumhauer. The network helps show where Annette Baumhauer may publish in the future.

Co-authorship network of co-authors of Annette Baumhauer

This figure shows the co-authorship network connecting the top 25 collaborators of Annette Baumhauer. A scholar is included among the top collaborators of Annette Baumhauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annette Baumhauer. Annette Baumhauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Symeonides, Stefan N., Devalingam Mahalingam, Young Kwang Chae, et al.. (2021). 525 Preliminary safety, PK/PD and efficacy results from a first-in-human phase I/IIa clinical trial of BNT411, a systemic Toll-like receptor 7 agonist in patients with solid tumors. SHILAP Revista de lepidopterología. A555–A555. 3 indexed citations
2.
Finn, Richard S., Philippe Merle, Alessandro Granito, et al.. (2018). Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial. Journal of Hepatology. 69(2). 353–358. 246 indexed citations
3.
Han, Guohong, Philippe Merle, Alessandro Granito, et al.. (2018). 4:12 PM Abstract No. 379 Updated overall survival (OS) analysis from the international, phase 3, randomized, placebo-controlled RESORCE trial of regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment. Journal of Vascular and Interventional Radiology. 29(4). S162–S163. 1 indexed citations
4.
Bruix, Jordi, Philippe Merle, Alessandro Granito, et al.. (2018). Hand-foot skin reaction (HFSR) and overall survival (OS) in the phase 3 RESORCE trial of regorafenib for treatment of hepatocellular carcinoma (HCC) progressing on sorafenib.. Journal of Clinical Oncology. 36(4_suppl). 412–412. 36 indexed citations
5.
6.
Finn, Richard S., Philippe Merle, Alessandro Granito, et al.. (2017). Outcomes with sorafenib (SOR) followed by regorafenib (REG) or placebo (PBO) for hepatocellular carcinoma (HCC): Results of the international, randomized phase 3 RESORCE trial.. Journal of Clinical Oncology. 35(4_suppl). 344–344. 21 indexed citations
7.
Galle, Peter R., Philippe Merle, Alessandro Granito, et al.. (2017). Outcomes with sorafenib (SOR) followed by regorafenib (REG) or placebo (PBO) for hepatocellular carcinoma (HCC): Results of the international, randomized phase 3 RESORCE trial. Zeitschrift für Gastroenterologie. 3 indexed citations
8.
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Lamar Breakdown of academic impact, for papers by Liangliang Qiao Breakdown of academic impact, for papers by Yu-Jie Xu Breakdown of academic impact, for papers by Ruocai Xu Breakdown of academic impact, for papers by Fei Cao Breakdown of academic impact, for papers by Songqiang Zhou Breakdown of academic impact, for papers by Guohong Han Breakdown of academic impact, for papers by Xuqi Sun Breakdown of academic impact, for papers by J. Zou
Rankless by CCL
2026